Expanded Access Protocol of ZULRESSO™ (Brexanolone) Injection for Adult Patients With Postpartum Depression

NCT03924492 · clinicaltrials.gov ↗

APPROVED_FOR_MARKETING

Status

INDUSTRY

Sponsor class

Conditions

Postpartum Depression

Interventions

DRUG: ZULRESSO (brexanolone) injection

Sponsor

Supernus Pharmaceuticals, Inc.